P115 Low grade dysplasia prognosis in the 21st century – a large multi-centre retrospective cohort study

医学 发育不良 回顾性队列研究 彩色内窥镜 内科学 溃疡性结肠炎 结肠镜检查 队列 累积发病率 结肠切除术 胃肠病学 比例危险模型 结直肠癌 外科 癌症 疾病
作者
Misha Kabir,Kit Curtius,Ibrahim Al Bakir,Chang-Ho Ryan Choi,Juanda Leo Hartono,Michael A. Johnson,James E. East,James O. Lindsay,Roser Vega,Siwan Thomas‐Gibson,Ailsa Hart,Trevor A. Graham,Ana Wilson
标识
DOI:10.1136/gutjnl-2020-bsgcampus.190
摘要

Introduction

Recent advances in ulcerative colitis (UC) endoscopic surveillance such as high-definition imaging and greater chromoendoscopy (CE) use have led to an increase in detection and resection of visible dysplasia. An updated study of prognosis of low grade dysplasia (LGD) is needed to address uncertainty as to the accuracy of progression rates based on historical studies.

Methods

This retrospective cohort study involved four UK IBD centres. Hospital pathology databases were searched between 1 January 2001 and 30 December 2018 to identify adult patients with UC who had their first LGD diagnosis diagnosed within the extent of colitis. Only patients followed up with at least one colonoscopy or colectomy by 30 August 2019 were included. The study end point was time to high grade dysplasia or cancer, i.e. advanced neoplasia (AN), or end of follow-up. Kaplan-Meier and Cox proportional hazards model survival analyses were performed.

Results

460 patients met the inclusion criteria and were followed up for a median of 4.1 years (2,2201 patient-years). 77% of patients had CE surveillance. Complete endoscopic resection was achieved in 94% and 64% of the polypoid and non-polypoid LGD respectively. Incidence rate of AN per 100 patient-years was 1.0 (95% CI 0.6–1.7) after endoscopic resection of polypoid LGD, 2.5 (95% CI 1.3–4.4) after resection of non-polypoid LGD resection and 8.9 (95% CI 6.0–12.6) if the LGD was unresected. Figure 1 demonstrates the cumulative incidence of AN according to LGD visibility and resectability. On multivariate analysis, predictors of AN progression were visible LGD of 1 cm diameter or more [Hazard ratio (HR) 2.5; 95% CI 1.4–4.45; p=0.002], multifocality [HR 1.8; 95% CI 1.1–3.2; p=0.046] and incomplete endoscopic resection, including invisible dysplasia [HR 5.8; 95% CI 3.3–10.1; p<0.001].

Conclusions

This is the largest study this century to examine prognosis of LGD based on endoscopic features. Incidence of AN is low if visible LGD is endoscopically resected but large size, multifocality and co-existent invisible LGD increase this risk and should be considered when decision-making.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
hhhh发布了新的文献求助30
刚刚
刚刚
念念不忘完成签到,获得积分10
刚刚
刚刚
专注之双完成签到,获得积分10
1秒前
思源的应助被战神幽默采纳,获得10
1秒前
CipherSage的应助被丰富芙采纳,获得10
1秒前
juju816完成签到,获得积分10
1秒前
Xenophobia发布了新的文献求助10
2秒前
3秒前
深情的皮皮虾的应助被zhouyane采纳,获得10
3秒前
4秒前
v0id的应助被木同采纳,获得10
4秒前
小二郎的应助被甜蜜的松思采纳,获得10
5秒前
5秒前
领导范儿的应助被百事可乐采纳,获得10
5秒前
hhhh完成签到,获得积分20
5秒前
5秒前
豆豆发布了新的文献求助10
6秒前
初景发布了新的文献求助10
6秒前
大模型的应助被李佳然采纳,获得10
6秒前
逸仙人完成签到,获得积分10
7秒前
肖子俊发布了新的文献求助10
8秒前
不吵完成签到,获得积分10
8秒前
houniao发布了新的文献求助10
8秒前
赘婿的应助被wu采纳,获得10
9秒前
Wuxxi完成签到,获得积分10
9秒前
kyu发布了新的文献求助10
9秒前
10秒前
李健的应助被GGbond采纳,获得10
10秒前
安详凡松完成签到,获得积分10
10秒前
充电宝的应助被机智的凡霜采纳,获得10
11秒前
周星星发布了新的文献求助10
11秒前
11秒前
冷静汉堡完成签到,获得积分10
12秒前
Lisisi的应助被木同采纳,获得10
12秒前
薛雨霄发布了新的文献求助10
12秒前
wanci的应助被顾文采纳,获得10
13秒前
13秒前
ding的应助被稳重的山柏采纳,获得10
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Aspects of Post-SPE Phonology 2000
Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals 888
Rosenblum, Global Change Biology 800
Holistic Discourse Analysis, Second Edition by Robert E. Longacre (2012-09-10) 666
Final Report for the 2-D Test of Model 901 Rotor and Wing Airfoils (BSWT 592) 528
Berberine regulates the TLR4 signaling pathway to suppress hypoxia-induced proliferation and migration of pulmonary arterial smooth muscle cells 520
热门求助领域 (近24小时)
化学 材料科学 医学 生物 计算机科学 工程类 纳米技术 物理 有机化学 化学工程 内科学 生物化学 复合材料 催化作用 心理学 细胞生物学 无机化学 电极 光电子学 人工智能
热门帖子
关注 科研通微信公众号,转发送积分 7876813
求助须知:如何正确求助?哪些是违规求助? 9392114
关于积分的说明 20791481
捐赠科研通 7478861
什么是DOI,文献DOI怎么找? 3353177
关于科研通互助平台的介绍 2493300
邀请新用户注册赠送积分活动 2379980